How pharmacy law works in Turkey: who can own a pharmacy, licensing and location rules, SGK reimbursement, pricing, advertising bans, inspections, sanctions, and how to stay compliant.
Pharmacy Law in Turkey: A Practical Legal Guide for Pharmacies, Investors, and Healthcare Businesses
Pharmacy law in Turkey sits at the intersection of public health, professional regulation, and a tightly supervised medicines market. For pharmacy owners, wholesalers, pharmaceutical companies, healthcare startups, and even foreign investors exploring opportunities, Turkey’s framework is not “business as usual.” It is a compliance-heavy area where licensing, location rules, pricing and reimbursement, advertising restrictions, and inspections are all designed to prioritize patient safety and traceability.
This guide explains the core legal architecture governing community pharmacies (“serbest eczane”), the role of regulators, and the main risk areas that typically create disputes—such as licensing refusals, relocation/transfer conflicts, SGK reimbursement issues, promotional violations, and illegal online sales. The goal is to provide a client-friendly but legally accurate overview you can rely on when planning, investing, or defending your operations.
1) Regulatory Authorities You Must Understand
Several public institutions shape pharmacy practice and the medicine supply chain in Turkey:
- Republic of Türkiye Ministry of Health: Sets national health policy and is the primary public authority behind health legislation and secondary regulations affecting pharmacies and medicines.
- Turkish Medicines and Medical Devices Agency (TİTCK): Central regulator for medicines and medical devices; its systems and regulatory approach strongly affect dispensing, traceability, and compliance expectations.
- Provincial/Local Health Directorates: Handle practical licensing steps (opening, relocation, transfer procedures) and inspections in many day-to-day matters.
- Social Security Institution (SGK): The key “payer” and reimbursement decision-maker for financed medicines; its reimbursement framework materially impacts pharmacy revenue and operational rules.
- Turkish Pharmacists’ Association (TEB) and regional chambers: Professional self-governance, ethics, discipline, and sector coordination under their founding law.
Why this matters: Many pharmacy disputes are not “court-first.” They start as administrative decisions (refusals, sanctions, inspections, reimbursement consequences). Understanding which authority owns which decision is the difference between a fast solution and a long, expensive dispute.
2) Core Legal Sources: The Backbone of Pharmacy Law
Turkey’s pharmacy ecosystem is primarily governed by a combination of laws and detailed secondary legislation. The most frequently referenced sources include:
- Law No. 6197 (Eczacılar ve Eczaneler Hakkında Kanun) – the cornerstone statute governing pharmacists and pharmacies (who can operate, licensing logic, restrictions, sanctions, and key prohibitions).
- Secondary regulations on pharmacists/pharmacies (notably the 2014 regulation commonly used in practice for opening/relocation/operation rules).
- Law No. 6643 (Eczacılar Birliği Kanunu / Turkish Pharmacists’ Association Law) – professional organization, duties, and disciplinary structure.
- Rules on promotion/advertising of medicinal products – key for compliance of communications and promotional activities.
- Drug pricing and reimbursement framework – including pricing decisions and SGK reimbursement rules and lists affecting which medicines are funded and on what terms.
3) Who Can Own and Operate a Community Pharmacy in Turkey?
3.1 Pharmacist-only model (ownership + responsible management)
Turkey’s model is built around the pharmacist as both the owner and the professionally responsible manager of a community pharmacy. In practice, a “serbest eczane” is tied to pharmacist ownership and pharmacist management, which significantly limits typical corporate “chain pharmacy” structures. This is not only a business rule—it is a public-health design choice reflected in the legal texts and implementing regulations.
3.2 Why the model is strict
From the regulator’s perspective, dispensing medicines is not an ordinary retail activity. It includes:
- professional judgment and patient safety duties,
- strict storage and traceability requirements,
- liability exposure for controlled medicines and prescription handling.
Therefore, the legal architecture pushes accountability onto a licensed professional, not an anonymous corporate layer.
4) Licensing & Location: Opening a Pharmacy Is Not “Free Market”
4.1 Population-based planning (the “3,500 persons per pharmacy” rule)
A key feature of Turkish pharmacy law is that the number of community pharmacies in a district is planned according to population. The widely applied standard is at least 3,500 persons per pharmacy within district boundaries, with specific exceptions (e.g., settlements with no pharmacy).
Practical impact: Even if you are fully qualified, you may not be able to open where you want unless the location is available under the planning quota and placement procedures.
4.2 Placement/selection mechanisms (EYS practice)
Turkey has operated placement-oriented approaches in pharmacy opening/relocation processes, including systems and guides published for pharmacist placement applications.
4.3 Exceptions you must know
The framework recognizes special cases. For example, where a settlement unit has no pharmacy, opening may be permitted without applying the population criterion, but later relocation can trigger the population criterion again.
4.4 Opening vs relocation vs transfer
Legally and practically, authorities treat these differently:
- Opening (first licensing): assessed under the planning criteria and licensing documentation.
- Relocation (nakil): may have different constraints; intra-district relocations can be treated differently than cross-district moves in practice.
- Transfer (devir): typically involves both professional and administrative considerations (continuity, compliance history, premises suitability).
Client takeaway: The fastest way to a “yes” is structuring the project around the correct category from day one—many refusals happen simply because applicants present a relocation like an opening (or vice versa).
5) Operating Rules: What Compliance Looks Like in Daily Pharmacy Practice
Even after licensing, the real legal risk starts with operations. The most common compliance pillars include:
5.1 Prescription dispensing and professional duties
Dispensing is not a mechanical act. A compliant pharmacy is expected to:
- dispense only in line with prescription status and controlled-substance rules,
- maintain correct records,
- protect patients from misuse and counterfeit risks,
- comply with storage and safety standards.
5.2 Controlled substances and restricted products
Turkey treats certain substances as high-risk. Violations can trigger:
- administrative sanctions (including closure steps in severe cases),
- criminal exposure depending on the conduct and applicable penal provisions,
- disciplinary proceedings from professional bodies.
5.3 Inspections and administrative enforcement
Inspections can be complaint-driven or periodic. Typical findings include:
- recordkeeping gaps,
- improper storage conditions,
- non-compliant sale of pharmacy-only products through improper channels,
- promotion/advertising violations,
- traceability errors.
When enforcement actions occur, legal strategy usually requires an immediate assessment of:
- the legal basis of the action,
- procedural compliance (notification, evidence, competence),
- proportionality and whether suspension (stay of execution) is available through administrative litigation.
6) Traceability & Anti-Counterfeiting: The Drug Tracking System (İTS)
Turkey is internationally known for implementing a national track-and-trace model for medicines. The Drug Tracking System (İlaç Takip Sistemi / İTS) is designed to prevent counterfeit, illegal, or expired products reaching patients and to monitor the supply chain from production/import to the end user.
Why this is legally important:
- Traceability is not merely “IT.” It is a compliance obligation.
- Traceability issues can trigger audits, reimbursement consequences, and administrative actions.
- For distributors and manufacturers, incorrect serialization/notification practices can escalate quickly into market access problems.
7) Pricing of Medicines in Turkey: Reference Pricing Logic
7.1 Central pricing model
Turkey uses a structured pricing system for human medicinal products, built around a pricing decision framework and related communiqués/guidance.
A notable concept in the system is reference pricing, where the reference country basket and defined rules affect maximum price calculations (the details and definitions are provided in the pricing communiqués/changes).
7.2 Business risk: pricing is legally regulated, not negotiated
Unlike many sectors where pricing is primarily contractual, medicine pricing in Turkey is heavily regulated. For compliance:
- companies must track regulatory changes and official publications,
- pricing updates can affect inventory strategy, procurement timing, and reimbursement outcomes.
8) Reimbursement (SGK): The Financial Engine Behind Dispensing
For many medicines, what matters commercially is not only the sale price but whether the product is funded by SGK and under what conditions.
SGK’s reimbursement rules are governed by specific regulations and by the Health Implementation Communiqué (SUT) and its annex lists and updates.
Typical legal hotspots:
- disputes about reimbursement eligibility or conditions,
- audit findings tied to prescription compliance,
- protocol compliance issues (documentation, reporting, traceability correlation),
- retrospective financial claims when SGK alleges improper reimbursement.
Practical advice for businesses: Treat reimbursement compliance like tax compliance—documented, systematic, and audit-ready.
9) Advertising, Promotion, and Digital Presence: Where Many Pharmacies Get Into Trouble
9.1 Ban on internet sale of medicines & restrictions on pharmacy websites
One of the clearest rules emphasized in sector communications is that medicines cannot be sold via the internet or other electronic platforms, and pharmacies/pharmacists face strict boundaries regarding operating websites under the pharmacy name for sales purposes.
This is a frequent enforcement area because:
- e-commerce platforms may list regulated products,
- third parties may sell “pharmacy-only” items online,
- social media promotion can be interpreted as advertising or solicitation.
9.2 Promotion rules for medicinal products
Separate from pharmacy advertising, Turkey also regulates promotional activities for human medicinal products through specific legislation and guidance.
Compliance mindset: If your marketing team treats medicines like cosmetics, you are exposed. Promotions and communications must be assessed under the specific promotion regime, not general consumer marketing logic.
10) Professional Discipline: The “Second Track” of Risk
Pharmacy law risk is not only administrative or criminal; it is also professional.
Under the professional organization framework, pharmacists may face:
- ethics and discipline processes,
- chamber-level investigations,
- sanctions that can compound administrative problems.
Because professional discipline can affect reputation and continuity of operations, dispute management should be coordinated: one consistent defense strategy across administrative files, professional bodies, and (if needed) court actions.
11) Sanctions and Liability: What Happens When Things Go Wrong?
11.1 Administrative measures (including closure risks)
Law No. 6197 contains enforcement-oriented provisions and sanctions logic, including consequences for operating without proper authorization and rapid closure mechanics in certain cases.
11.2 Criminal exposure (case-dependent)
Depending on conduct (e.g., illegal sale of restricted substances, intentional counterfeit distribution), criminal law risks can arise. The correct legal response depends on:
- the exact product category,
- intent and knowledge,
- supply chain evidence,
- whether the event is treated as an administrative noncompliance or a criminally relevant act.
11.3 Civil liability
Pharmacies and healthcare businesses can face:
- consumer claims,
- product-related damage claims (fact-specific),
- employment disputes,
- contractual disputes with distributors or service providers.
12) Common Disputes and How Legal Strategy Typically Works
In practice, “pharmacy law cases” frequently appear in these categories:
- License refusal or placement disputes
Often resolved through administrative objections and, if necessary, administrative court litigation. - Relocation/transfer conflicts
Usually technical: population criterion, category misclassification, premises compliance, timing, and procedural issues. - Inspection-based sanctions
Defense focuses on competence, procedure, evidence, proportionality, and corrective actions. - SGK reimbursement disputes
Requires documentary discipline and often expert-level analysis of SUT rules and dispensing records. - Advertising and online-sale allegations
Requires careful separation of: (i) medicine sales, (ii) pharmacy-only product distribution rules, and (iii) general informational content—each has different legal implications.
Strategic note: The strongest outcomes usually come from a dual track:
- immediate compliance remediation (to stop escalation), and
- a procedural/legal challenge where the authority overreached or misapplied criteria.
13) Practical Compliance Checklist (Pharmacies & Healthcare Businesses)
Use this as an internal “audit lens”:
- Licensing file is complete and consistent with the correct transaction type (opening vs relocation vs transfer).
- Premises and operational setup match regulatory requirements (storage, access, signage, documentation).
- Traceability processes are working, staff trained, and records are audit-ready (İTS-related workflows).
- A written policy exists for controlled substances and restricted products.
- SGK reimbursement compliance is treated as a “hard control” area (documentation discipline, internal review, periodic checks).
- Marketing content is reviewed under promotion/advertising constraints; no accidental “sales solicitation” via social media.
- A response protocol exists for inspections (who speaks, which documents are delivered, how statements are recorded).
14) FAQ: Pharmacy Law in Turkey
Can anyone open a pharmacy in Turkey?
Community pharmacies are structured around pharmacist eligibility and ownership/management requirements, not general investor ownership. The applicable rules are grounded in Law No. 6197 and implementing regulations.
Is there a limit on where I can open a pharmacy?
Yes. The system applies population-based planning (commonly expressed as at least 3,500 persons per pharmacy within district boundaries) and includes exceptions for settlements with no pharmacy.
Can a pharmacy sell medicines online in Turkey?
As emphasized in sector guidance tied to Law No. 6197, online sale of medicines is prohibited, and pharmacies face strict limitations in this area.
Who regulates medicines and traceability?
TİTCK is the key regulator in this space, and Turkey’s Drug Tracking System (İTS) supports supply-chain traceability and anti-counterfeiting controls.
How does SGK affect pharmacies?
SGK is central to drug reimbursement and applies its own reimbursement regulation and SUT framework, which can create audit exposure if dispensing and documentation do not match reimbursement conditions.
Conclusion: Turning Compliance Into Business Security
Pharmacy law in Turkey is built on a public-health logic: pharmacist-centered accountability, planned licensing and location criteria, strict traceability expectations, regulated pricing, and reimbursement discipline. For pharmacies and healthcare businesses, success is not only about commercial strategy—it is about building a defensible compliance structure that can withstand inspections, reimbursement audits, and digital-era advertising risks.
If you are planning to open, relocate, transfer, or invest in a pharmacy-related business—or if you are facing a licensing refusal, inspection sanction, or SGK reimbursement dispute—your legal position improves dramatically when you act early, preserve evidence, correct operational gaps, and challenge unlawful administrative steps through the correct procedural channels.
Yanıt yok